biotage gb limited Company Information
Company Number
01033865
Next Accounts
Sep 2025
Shareholders
biotage ab
Group Structure
View All
Industry
Manufacture of other chemical products n.e.c.
+1Registered Address
biotage gb limited, distribution way, hengoed, mid glamorgan, CF82 7TS
Website
www.biotage.combiotage gb limited Estimated Valuation
Pomanda estimates the enterprise value of BIOTAGE GB LIMITED at £21m based on a Turnover of £27.5m and 0.76x industry multiple (adjusted for size and gross margin).
biotage gb limited Estimated Valuation
Pomanda estimates the enterprise value of BIOTAGE GB LIMITED at £6.2m based on an EBITDA of £1.2m and a 5.21x industry multiple (adjusted for size and gross margin).
biotage gb limited Estimated Valuation
Pomanda estimates the enterprise value of BIOTAGE GB LIMITED at £21m based on Net Assets of £10.7m and 1.97x industry multiple (adjusted for liquidity).
Edit your figures and get a professional valuation report.
Biotage Gb Limited Overview
Biotage Gb Limited is a live company located in hengoed, CF82 7TS with a Companies House number of 01033865. It operates in the manufacture of other chemical products n.e.c. sector, SIC Code 20590. Founded in December 1971, it's largest shareholder is biotage ab with a 100% stake. Biotage Gb Limited is a mature, large sized company, Pomanda has estimated its turnover at £27.5m with healthy growth in recent years.
Upgrade for unlimited company reports & a free credit check
Biotage Gb Limited Health Check
Pomanda's financial health check has awarded Biotage Gb Limited a 2 rating. We use a traffic light system to show it exceeds the industry average on 4 measures and has 7 areas for improvement. Company Health Check FAQs


4 Strong

1 Regular

7 Weak

Size
annual sales of £27.5m, make it larger than the average company (£17.3m)
£27.5m - Biotage Gb Limited
£17.3m - Industry AVG

Growth
3 year (CAGR) sales growth of 14%, show it is growing at a faster rate (7.3%)
14% - Biotage Gb Limited
7.3% - Industry AVG

Production
with a gross margin of 20.5%, this company has a higher cost of product (32.5%)
20.5% - Biotage Gb Limited
32.5% - Industry AVG

Profitability
an operating margin of 1.5% make it less profitable than the average company (6.1%)
1.5% - Biotage Gb Limited
6.1% - Industry AVG

Employees
with 154 employees, this is above the industry average (67)
154 - Biotage Gb Limited
67 - Industry AVG

Pay Structure
on an average salary of £42.5k, the company has an equivalent pay structure (£52.8k)
£42.5k - Biotage Gb Limited
£52.8k - Industry AVG

Efficiency
resulting in sales per employee of £178.4k, this is less efficient (£270.6k)
£178.4k - Biotage Gb Limited
£270.6k - Industry AVG

Debtor Days
it gets paid by customers after 1 days, this is earlier than average (55 days)
1 days - Biotage Gb Limited
55 days - Industry AVG

Creditor Days
its suppliers are paid after 17 days, this is quicker than average (40 days)
17 days - Biotage Gb Limited
40 days - Industry AVG

Stock Days
it holds stock equivalent to 146 days, this is more than average (89 days)
146 days - Biotage Gb Limited
89 days - Industry AVG

Cash Balance
has cash to cover current liabilities for 10 weeks, this is less cash available to meet short term requirements (13 weeks)
10 weeks - Biotage Gb Limited
13 weeks - Industry AVG

Debt Level
it has a ratio of liabilities to total assets of 47.4%, this is a higher level of debt than the average (41.4%)
47.4% - Biotage Gb Limited
41.4% - Industry AVG
BIOTAGE GB LIMITED financials

Biotage Gb Limited's latest turnover from December 2023 is £27.5 million and the company has net assets of £10.7 million. According to their latest financial statements, Biotage Gb Limited has 154 employees and maintains cash reserves of £1.6 million as reported in the balance sheet.
Data source: Companies House, Pomanda Estimates
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Turnover | 27,475,978 | 31,008,094 | 25,389,271 | 18,462,335 | 17,675,259 | 16,477,935 | 14,221,711 | 12,415,486 | 12,647,607 | 10,891,916 | 7,592,781 | 6,649,902 | 5,983,291 | 5,962,730 | 5,172,390 |
Other Income Or Grants | |||||||||||||||
Cost Of Sales | 21,845,844 | 24,044,741 | 19,843,734 | 13,794,708 | 13,093,697 | 11,359,061 | 10,129,029 | 8,855,403 | 8,421,351 | 8,089,520 | 6,200,652 | 4,797,101 | 4,320,506 | 4,256,070 | 3,817,440 |
Gross Profit | 5,630,134 | 6,963,353 | 5,545,537 | 4,667,627 | 4,581,562 | 5,118,874 | 4,092,682 | 3,560,083 | 4,226,256 | 2,802,396 | 1,392,129 | 1,852,801 | 1,662,785 | 1,706,660 | 1,354,950 |
Admin Expenses | 5,208,073 | 4,262,953 | 3,829,586 | 3,714,318 | 3,765,248 | 3,639,253 | 3,369,856 | 3,471,956 | 3,372,720 | 2,315,341 | 1,096,832 | 1,057,196 | 1,012,913 | 939,193 | 1,071,931 |
Operating Profit | 422,061 | 2,700,400 | 1,715,951 | 953,309 | 816,314 | 1,479,621 | 722,826 | 88,127 | 853,536 | 487,055 | 295,297 | 795,605 | 649,872 | 767,467 | 283,019 |
Interest Payable | 167,969 | 9,475 | 9,357 | 13,080 | 9,675 | 10,119 | 13,265 | 12,735 | 12,249 | 13,062 | 17,530 | 25,742 | |||
Interest Receivable | 757 | 48,459 | 317,053 | 287,748 | 206,040 | 179,783 | 171,149 | 165,003 | |||||||
Pre-Tax Profit | 254,092 | 2,690,925 | 1,706,594 | 940,229 | 806,639 | 1,479,621 | 723,583 | 88,127 | 907,376 | 790,843 | 570,310 | 989,396 | 816,593 | 921,086 | 422,280 |
Tax | -124,462 | -535,738 | -419,034 | -229,785 | -161,196 | -294,450 | -45,872 | -97,900 | -178,992 | -49,728 | -100,203 | -237,110 | -236,166 | -262,510 | -9,401 |
Profit After Tax | 129,630 | 2,155,187 | 1,287,560 | 710,444 | 645,443 | 1,185,171 | 677,711 | -9,773 | 728,384 | 741,115 | 470,107 | 752,286 | 580,427 | 658,576 | 412,879 |
Dividends Paid | 1,899,381 | 4,675,950 | |||||||||||||
Retained Profit | 129,630 | 2,155,187 | 1,287,560 | 710,444 | 645,443 | 1,185,171 | 677,711 | -9,773 | -1,170,997 | -3,934,835 | 470,107 | 752,286 | 580,427 | 658,576 | 412,879 |
Employee Costs | 6,541,254 | 6,264,987 | 5,594,355 | 5,260,562 | 5,023,848 | 4,911,129 | 4,345,175 | 4,262,777 | 4,056,412 | 3,421,120 | 2,533,364 | 2,442,750 | 2,394,293 | 2,365,377 | 2,321,333 |
Number Of Employees | 154 | 153 | 146 | 141 | 141 | 134 | 125 | 119 | 116 | 108 | 100 | 97 | 95 | 98 | 96 |
EBITDA* | 1,183,909 | 3,504,180 | 2,449,804 | 1,744,503 | 1,610,741 | 1,864,177 | 1,465,867 | 470,269 | 1,237,979 | 812,321 | 549,820 | 1,034,506 | 883,495 | 999,670 | 477,199 |
* Earnings Before Interest, Tax, Depreciation and Amortisation
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Tangible Assets | 4,971,094 | 5,461,555 | 4,501,784 | 3,680,869 | 3,143,295 | 2,444,459 | 2,099,704 | 1,756,933 | 1,688,139 | 1,837,726 | 1,738,857 | 1,650,747 | 1,588,072 | 1,558,695 | 1,629,985 |
Intangible Assets | 1,324,367 | ||||||||||||||
Investments & Other | |||||||||||||||
Debtors (Due After 1 year) | |||||||||||||||
Total Fixed Assets | 6,295,461 | 5,461,555 | 4,501,784 | 3,680,869 | 3,143,295 | 2,444,459 | 2,099,704 | 1,756,933 | 1,688,139 | 1,837,726 | 1,738,857 | 1,650,747 | 1,588,072 | 1,558,695 | 1,629,985 |
Stock & work in progress | 8,758,900 | 8,987,208 | 6,678,525 | 4,919,339 | 5,144,550 | 4,271,082 | 3,076,078 | 2,924,292 | 2,984,177 | 3,117,968 | 2,569,108 | 1,830,364 | 1,489,117 | 1,822,032 | 1,795,183 |
Trade Debtors | 105,985 | 101,416 | 106,694 | 18,815 | |||||||||||
Group Debtors | 2,097,610 | 1,509,920 | 2,922,973 | 2,145,701 | 649,273 | 669,292 | 2,444,712 | 6,374,757 | 5,994,655 | 5,806,616 | 4,968,151 | 4,334,044 | |||
Misc Debtors | 1,488,884 | 867,653 | 967,592 | 669,651 | 739,232 | 648,094 | 567,291 | 449,397 | 473,701 | 666,618 | 420,280 | 240,723 | 234,162 | 218,647 | 193,392 |
Cash | 1,590,217 | 179,591 | 286,431 | 564,704 | 437,870 | 280,968 | 466,437 | 144,273 | 156,821 | 51,434 | 49,050 | 150,253 | 64,210 | 27,789 | 59,985 |
misc current assets | 52,484 | 24,032 | |||||||||||||
total current assets | 14,041,596 | 11,645,788 | 10,962,215 | 8,318,210 | 6,321,652 | 5,252,628 | 4,109,806 | 4,191,267 | 4,283,991 | 6,280,732 | 9,413,195 | 8,215,995 | 7,594,105 | 7,036,619 | 6,382,604 |
total assets | 20,337,057 | 17,107,343 | 15,463,999 | 11,999,079 | 9,464,947 | 7,697,087 | 6,209,510 | 5,948,200 | 5,972,130 | 8,118,458 | 11,152,052 | 9,866,742 | 9,182,177 | 8,595,314 | 8,012,589 |
Bank overdraft | |||||||||||||||
Bank loan | 58,000 | 41,365 | 41,365 | 41,365 | 41,365 | 41,365 | |||||||||
Trade Creditors | 1,066,093 | 1,118,341 | 737,339 | 827,775 | 2,337,875 | 729,621 | 549,555 | 595,261 | 646,158 | 869,462 | 459,505 | 208,953 | 269,005 | 170,514 | 329,047 |
Group/Directors Accounts | 5,709,200 | 3,435,570 | 4,411,772 | 2,215,841 | 100,943 | 594,353 | 457,256 | 912,756 | 629,271 | ||||||
other short term finances | |||||||||||||||
hp & lease commitments | 244,991 | 185,016 | 228,388 | 257,799 | 11,435 | 23,426 | 16,172 | ||||||||
other current liabilities | 712,559 | 1,103,327 | 943,721 | 750,736 | 44,103 | 936,461 | 776,769 | 586,952 | 688,573 | 536,191 | 329,014 | 431,475 | 388,695 | 482,777 | 353,430 |
total current liabilities | 7,732,843 | 5,842,254 | 6,321,220 | 4,052,151 | 2,381,978 | 1,666,082 | 1,427,267 | 1,776,566 | 1,803,422 | 2,399,835 | 1,475,327 | 681,793 | 699,065 | 694,656 | 723,842 |
loans | 357,110 | 430,989 | 488,373 | 547,932 | 606,849 | 663,024 | |||||||||
hp & lease commitments | 1,097,865 | 99,287 | 220,639 | 467,432 | 11,796 | 46,020 | |||||||||
Accruals and Deferred Income | 8,143 | 40,699 | 446,569 | 105,810 | 59,033 | 72,921 | 86,810 | 100,695 | |||||||
other liabilities | |||||||||||||||
provisions | 807,516 | 596,599 | 499,981 | 312,341 | 220,388 | 154,626 | 137,812 | 191,026 | 164,438 | 160,565 | 123,248 | 90,215 | 81,105 | 20,161 | 10,651 |
total long term liabilities | 1,905,381 | 695,886 | 728,763 | 820,472 | 666,957 | 260,436 | 196,845 | 263,947 | 251,248 | 630,166 | 600,257 | 578,588 | 629,037 | 627,010 | 673,675 |
total liabilities | 9,638,224 | 6,538,140 | 7,049,983 | 4,872,623 | 3,048,935 | 1,926,518 | 1,624,112 | 2,040,513 | 2,054,670 | 3,030,001 | 2,075,584 | 1,260,381 | 1,328,102 | 1,321,666 | 1,397,517 |
net assets | 10,698,833 | 10,569,203 | 8,414,016 | 7,126,456 | 6,416,012 | 5,770,569 | 4,585,398 | 3,907,687 | 3,917,460 | 5,088,457 | 9,076,468 | 8,606,361 | 7,854,075 | 7,273,648 | 6,615,072 |
total shareholders funds | 10,698,833 | 10,569,203 | 8,414,016 | 7,126,456 | 6,416,012 | 5,770,569 | 4,585,398 | 3,907,687 | 3,917,460 | 5,088,457 | 9,076,468 | 8,606,361 | 7,854,075 | 7,273,648 | 6,615,072 |
Dec 2023 | Dec 2022 | Dec 2021 | Dec 2020 | Dec 2019 | Dec 2018 | Dec 2017 | Dec 2016 | Dec 2015 | Dec 2014 | Dec 2013 | Dec 2012 | Dec 2011 | Dec 2010 | Dec 2009 | |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Operating Activities | |||||||||||||||
Operating Profit | 422,061 | 2,700,400 | 1,715,951 | 953,309 | 816,314 | 1,479,621 | 722,826 | 88,127 | 853,536 | 487,055 | 295,297 | 795,605 | 649,872 | 767,467 | 283,019 |
Depreciation | 761,848 | 803,780 | 733,853 | 791,194 | 794,427 | 384,556 | 382,142 | 382,142 | 384,443 | 325,266 | 254,523 | 238,901 | 233,623 | 232,203 | 194,180 |
Amortisation | 360,899 | ||||||||||||||
Tax | -124,462 | -535,738 | -419,034 | -229,785 | -161,196 | -294,450 | -45,872 | -97,900 | -178,992 | -49,728 | -100,203 | -237,110 | -236,166 | -262,510 | -9,401 |
Stock | -228,308 | 2,308,683 | 1,759,186 | -225,211 | 873,468 | 1,195,004 | 151,786 | -59,885 | -133,791 | 548,860 | 738,744 | 341,247 | -332,915 | 26,849 | 1,795,183 |
Debtors | 1,213,490 | -1,518,270 | 1,163,092 | 2,094,935 | 91,138 | 80,803 | -531,379 | -44,323 | -1,968,337 | -3,683,707 | 559,659 | 194,600 | 853,980 | 659,362 | 4,527,436 |
Creditors | -52,248 | 381,002 | -90,436 | -1,510,100 | 1,608,254 | 180,066 | -45,706 | -50,897 | -223,304 | 409,957 | 250,552 | -60,052 | 98,491 | -158,533 | 329,047 |
Accruals and Deferred Income | -390,768 | 151,463 | 160,429 | 300,763 | -551,599 | 206,469 | 175,929 | -115,510 | 138,497 | 307,872 | -102,461 | 42,780 | -94,082 | 129,347 | 353,430 |
Deferred Taxes & Provisions | 210,917 | 96,618 | 187,640 | 91,953 | 65,762 | 16,814 | -53,214 | 26,588 | 3,873 | 37,317 | 33,033 | 9,110 | 60,944 | 9,510 | 10,651 |
Cash flow from operations | -157,834 | 2,807,112 | -633,875 | -1,472,390 | 1,607,356 | 697,269 | 1,876,597 | 336,758 | 3,080,181 | 4,652,586 | -667,662 | 253,387 | 191,617 | 31,273 | -5,161,693 |
Investing Activities | |||||||||||||||
capital expenditure | |||||||||||||||
Change in Investments | |||||||||||||||
cash flow from investments | |||||||||||||||
Financing Activities | |||||||||||||||
Bank loans | -58,000 | 16,635 | 41,365 | ||||||||||||
Group/Directors Accounts | 2,273,630 | -976,202 | 2,195,931 | 2,215,841 | -100,943 | -493,410 | 137,097 | -455,500 | 283,485 | 629,271 | |||||
Other Short Term Loans | |||||||||||||||
Long term loans | -357,110 | -73,879 | -57,384 | -59,559 | -58,917 | -56,175 | 663,024 | ||||||||
Hire Purchase and Lease Commitments | 1,058,553 | -164,724 | -276,204 | 725,231 | -11,435 | -23,787 | -26,970 | 62,192 | |||||||
other long term liabilities | |||||||||||||||
share issue | |||||||||||||||
interest | -167,969 | -9,475 | -9,357 | -13,080 | -9,675 | 757 | 38,340 | 303,788 | 275,013 | 193,791 | 166,721 | 153,619 | 139,261 | ||
cash flow from financing | 3,164,214 | -1,150,401 | 1,910,370 | 2,927,992 | -9,675 | -100,943 | -492,653 | 125,662 | -856,057 | 449,883 | 909,092 | 134,232 | 107,804 | 97,444 | 7,045,843 |
cash and cash equivalents | |||||||||||||||
cash | 1,410,626 | -106,840 | -278,273 | 126,834 | 156,902 | -185,469 | 322,164 | -12,548 | 105,387 | 2,384 | -101,203 | 86,043 | 36,421 | -32,196 | 59,985 |
overdraft | |||||||||||||||
change in cash | 1,410,626 | -106,840 | -278,273 | 126,834 | 156,902 | -185,469 | 322,164 | -12,548 | 105,387 | 2,384 | -101,203 | 86,043 | 36,421 | -32,196 | 59,985 |
biotage gb limited Credit Report and Business Information
Biotage Gb Limited Competitor Analysis

Perform a competitor analysis for biotage gb limited by selecting its closest rivals, whether from the MANUFACTURING sector, other large companies, companies in CF82 area or any other competitors across 12 key performance metrics.
biotage gb limited Ownership
BIOTAGE GB LIMITED group structure
Biotage Gb Limited has no subsidiary companies.
Ultimate parent company
BIOTAGE AB
#0030948
1 parent
BIOTAGE GB LIMITED
01033865
biotage gb limited directors
Biotage Gb Limited currently has 3 directors. The longest serving directors include Mr Christopher Williams (Nov 2007) and Mr Anders Wikstrom (Oct 2023).
officer | country | age | start | end | role |
---|---|---|---|---|---|
Mr Christopher Williams | United Kingdom | 61 years | Nov 2007 | - | Director |
Mr Anders Wikstrom | Sweden | 51 years | Oct 2023 | - | Director |
Mr Frederic Vanderhaegen | Wales | 57 years | Oct 2024 | - | Director |
P&L
December 2023turnover
27.5m
-11%
operating profit
422.1k
-84%
gross margin
20.5%
-8.75%
turnover
Turnover, or revenue, is the amount of sales generated by a company within the financial year.
Balance Sheet
December 2023net assets
10.7m
+0.01%
total assets
20.3m
+0.19%
cash
1.6m
+7.85%
net assets
Total assets minus all liabilities
biotage gb limited company details
company number
01033865
Type
Private limited with Share Capital
industry
20590 - Manufacture of other chemical products n.e.c.
27900 - Manufacture of other electrical equipment
incorporation date
December 1971
age
54
incorporated
UK
ultimate parent company
accounts
Full Accounts
last accounts submitted
December 2023
previous names
argonaut technologies limited (April 2007)
argonaut technologies international limited (December 2002)
accountant
-
auditor
AZETS AUDIT SERVICES
address
biotage gb limited, distribution way, hengoed, mid glamorgan, CF82 7TS
Bank
SVENSKA HANDELSBANKEN AB
Legal Advisor
AQUITY LAW
biotage gb limited Charges & Mortgages
A charge, or mortgage, refers to the rights a company gives to a lender in return for a loan, often in the form of security given over business assets.
We found 8 charges/mortgages relating to biotage gb limited. Currently there are 2 open charges and 6 have been satisfied in the past.
biotage gb limited Capital Raised & Share Issues BETA
When a company issues new shares, e.g. to new investors following a funding round, it is required to notify Companies House within one month of making an allotment of shares.
Click to start generating capital raising & share issue transactions for BIOTAGE GB LIMITED. This can take several minutes, an email will notify you when this has completed.
biotage gb limited Companies House Filings - See Documents
date | description | view/download |
---|